| Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia M Bogliolo, B Schuster, C Stoepker, B Derkunt, Y Su, A Raams, JP Trujillo, ... The American Journal of Human Genetics 92 (5), 800-806, 2013 | 380 | 2013 |
| Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5 M Buxadé, G Lunazzi, J Minguillón, S Iborra, R Berga-Bolaños, M Del Val, ... Journal of Experimental Medicine 209 (2), 379-393, 2012 | 182 | 2012 |
| Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5 J Aramburu, K Drews-Elger, A Estrada-Gelonch, J Minguillón, ... Biochemical pharmacology 72 (11), 1597-1604, 2006 | 168 | 2006 |
| Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-β1 biosynthesis, whereas higher doses of cyclosporin A trigger … J Minguillon, B Morancho, SJ Kim, M Lopez-Botet, J Aramburu Journal of leukocyte biology 77 (5), 748-758, 2005 | 54 | 2005 |
| Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice B Morancho, J Minguillón, JD Molkentin, C López-Rodríguez, J Aramburu BMC molecular biology 9, 1-13, 2008 | 53 | 2008 |
| Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1 G Hernández, MJ Ramírez, J Minguillón, P Quiles, G Ruiz de Garibay, ... Nature communications 9 (1), 967, 2018 | 43 | 2018 |
| Gefitinib and afatinib show potential efficacy for Fanconi anemia–related head and neck cancer H Montanuy, Á Martínez-Barriocanal, J Antonio Casado, L Rovirosa, ... Clinical Cancer Research 26 (12), 3044-3057, 2020 | 25 | 2020 |
| Chromosome fragility in the buccal epithelium in patients with Fanconi anemia MJ Ramírez, J Minguillón, S Loveless, K Lake, E Carrasco, N Stjepanovic, ... Cancer Letters 472, 1-7, 2020 | 20 | 2020 |
| Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients MJ Ramírez, R Pujol, JP Trujillo‐Quintero, J Minguillón, M Bogliolo, P Río, ... American Journal of Hematology 96 (8), 989-999, 2021 | 14 | 2021 |
| CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative J Luque, I Mendes, B Gomez, B Morte, M López de Heredia, E Herreras, ... Clinical Genetics 101 (5-6), 481-493, 2022 | 13 | 2022 |
| Epigenetic alterations in Fanconi anaemia: role in pathophysiology and therapeutic potential H Belo, G Silva, BA Cardoso, B Porto, J Minguillon, J Barbot, J Coutinho, ... PloS one 10 (10), e0139740, 2015 | 9 | 2015 |
| Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia R Errazquin, A Page, A Suñol, C Segrelles, E Carrasco, J Peral, ... Oral Oncology 134, 106184, 2022 | 7 | 2022 |
| Fanconi-like anemia related to a FANCM mutation JA Encarnación, P Cerezuela, I Español, MR García, C Manso, ... European Journal of Medical Genetics 65 (1), 104399, 2022 | 6 | 2022 |
| High content drug screening for Fanconi anemia therapeutics H Montanuy, C Camps-Fajol, J Carreras-Puigvert, M Häggblad, ... Orphanet Journal of Rare Diseases 15, 1-9, 2020 | 6 | 2020 |
| Therapeutic research in the crystal chromosome disease Fanconi anemia J Minguillón, J Surrallés Mutation Research/Genetic Toxicology and Environmental Mutagenesis 836, 104-108, 2018 | 5 | 2018 |
| Donor selection for adoptive cell therapy with CD45RA− memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype … K Al-Akioui-Sanz, B Pascual-Miguel, M Díaz-Almirón, C Mestre-Durán, ... Cytotherapy 25 (3), 330-340, 2023 | 4 | 2023 |
| Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia JA Casado, A Valeri, R Sanchez-Domínguez, P Vela, A López, S Navarro, ... The Journal of Clinical Investigation 132 (15), 2022 | 4 | 2022 |
| Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients P Riera, B Rodríguez-Santiago, A Lasa, L Gonzalez-Quereda, B Martín, ... Cancers 12 (8), 2245, 2020 | 2 | 2020 |
| Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations B Martín-Antonio, B Blanco, Á González-Murillo, L Hidalgo, J Minguillón, ... Frontiers in Immunology 15, 1386856, 2024 | 1 | 2024 |
| CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival J Minguillón, MJ Ramírez, L Rovirosa, P Bustamante-Madrid, ... Cancers 14 (2), 353, 2022 | 1 | 2022 |
